Humanwell Healthcare Valuation Multiples

Humanwell Healthcare is valued at $4.9B as of October 2026, a 1.6x revenue multiple. In the last fiscal year, Humanwell Healthcare revenue was $3.6B and Humanwell Healthcare EBITDA was $648M.

Humanwell Healthcare Overview

About Humanwell Healthcare

Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.


Founded

1993

HQ

China

Employees

17.6K

Financials (Last FY)

Revenue: $3.6B
EBITDA: $648M

EV

$5.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Humanwell Healthcare Financials

Humanwell Healthcare reported last fiscal year revenue of $3.6B and EBITDA of $648M.

In the same fiscal year, Humanwell Healthcare generated $1.7B in gross profit, $648M in EBITDA, and $277M in net income.

Revenue (LTM)


Humanwell Healthcare P&L

In the most recent fiscal year, Humanwell Healthcare reported revenue of $3.6B and EBITDA of $648M.

Humanwell Healthcare is profitable as of last fiscal year, with gross margin of 48%, EBITDA margin of 18%, and net margin of 8%.

See analyst estimates for Humanwell Healthcare
Last FY202320242025202620272028
Revenue$3.6B$3.6B$3.8B$3.6B
Gross Profit$1.7B$1.7B$1.7B$1.7B
Gross Margin48%46%45%48%
EBITDA$648M$675M$564M$648M
EBITDA Margin18%19%15%18%
EBIT Margin16%15%13%16%
Net Profit$277M$317M$197M$277M
Net Margin8%9%5%8%
Net Debt$679M---

Financial data powered by Morningstar, Inc.

Humanwell Healthcare Stock Performance

Humanwell Healthcare has current market cap of $4.9B, and enterprise value of $5.8B.

Market Cap Evolution


Humanwell Healthcare's stock price is $2.99.

Humanwell Healthcare share price increased by 4.5% in the last 30 days, and by 0.5% in the last year.

Humanwell Healthcare has an EPS (earnings per share) of $0.17.

See more trading valuation data for Humanwell Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5.8B$4.9B0.4%4.5%12.4%0.5%$0.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Humanwell Healthcare Valuation Multiples

Humanwell Healthcare trades at 1.6x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Humanwell Healthcare

EV / Revenue (LTM)


Humanwell Healthcare Financial Valuation Multiples

As of October 16, 2026, Humanwell Healthcare has market cap of $4.9B and EV of $5.8B.

Humanwell Healthcare has a P/E ratio of 17.6x.

Last FY202320242025202620272028
EV/Revenue1.6x1.6x1.5x1.6x
EV/EBITDA9.0x8.6x10.3x9.0x
EV/EBIT10.2x10.8x11.8x10.2x
EV/Gross Profit3.4x3.5x3.5x3.4x
P/E17.6x15.4x24.7x17.6x
EV/FCF21.7xn/m34.2x21.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Humanwell Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Humanwell Healthcare Margins & Growth Rates

Humanwell Healthcare grew revenue by 9% and net profit by 24% in the last fiscal year.

In the most recent fiscal year, Humanwell Healthcare reported gross margin of 48%, EBITDA margin of 18%, and net margin of 8%.

See estimated margins and future growth rates for Humanwell Healthcare

Humanwell Healthcare Margins

Last FY202420252026202720282029
Gross Margin48%45%48%46%
EBITDA Margin18%15%18%-
EBIT Margin16%13%16%15%
Net Margin8%5%8%9%
FCF Margin7%4%7%-

Humanwell Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%4%(5%)9%
Gross Profit Growth4%1%3%4%
EBITDA Growth-(16%)15%-
EBIT Growth(0%)(9%)17%(0%)
Net Profit Growth24%(38%)41%24%
FCF Growth-12703%58%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Humanwell Healthcare Operational KPIs

Humanwell Healthcare's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Humanwell Healthcare
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.1M---
S&M Expenses to Revenue14%14%13%14%
G&A Expenses to Revenue1%2%2%1%
R&D Expenses to Revenue6%6%6%6%
Opex to Revenue32%31%32%32%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Humanwell Healthcare Competitors

Humanwell Healthcare competitors include Shanghai RAAS, Oruka Therapeutics, Scholar Rock, Veradermics, Travere Therapeutics, Wantai BioPharm, CRISPR Therapeutics, Anthem Biosciences, Apotex Health and Regencell Bioscience.

Most Humanwell Healthcare public comparables operate across Biopharmaceuticals, BioTech, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Shanghai RAAS$1.1B$316M4.7x-16.4x-
Oruka Therapeutics-($122M)--(33.0x)(22.4x)
Scholar Rock-($383M)-1049.7x(12.1x)(11.0x)
Veradermics-($72M)--(55.7x)(35.9x)
Travere Therapeutics$491M$9M10.4x7.5x537.0x17.7x
Wantai BioPharm$272M($24M)15.7x-(176.6x)-
CRISPR Therapeutics-($558M)-103.9x(6.1x)(6.8x)
Anthem Biosciences$223M$93M21.9x19.9x52.6x50.6x

This data is available for Pro users. Sign up to see all Humanwell Healthcare competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Humanwell Healthcare

When was Humanwell Healthcare founded?Humanwell Healthcare was founded in 1993.
Where is Humanwell Healthcare headquartered?Humanwell Healthcare is headquartered in China.
How many employees does Humanwell Healthcare have?As of today, Humanwell Healthcare has over 17K employees.
Is Humanwell Healthcare publicly listed?Yes, Humanwell Healthcare is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Humanwell Healthcare?Humanwell Healthcare trades under 600079 ticker.
When did Humanwell Healthcare go public?Humanwell Healthcare went public in 1997.
Who are competitors of Humanwell Healthcare?Humanwell Healthcare main competitors include Shanghai RAAS, Oruka Therapeutics, Scholar Rock, Veradermics, Travere Therapeutics, Wantai BioPharm, CRISPR Therapeutics, Anthem Biosciences, Apotex Health, Regencell Bioscience.
What is the current market cap of Humanwell Healthcare?Humanwell Healthcare's current market cap is $4.9B.
What is the current revenue of Humanwell Healthcare?Humanwell Healthcare's last fiscal year revenue is $3.6B.
What is the current revenue growth of Humanwell Healthcare?Humanwell Healthcare revenue growth (vs. last FY) is 9%.
What is the current EV/Revenue multiple of Humanwell Healthcare?Current revenue multiple of Humanwell Healthcare is 1.6x.
Is Humanwell Healthcare profitable?No, Humanwell Healthcare is not profitable.
How many companies Humanwell Healthcare has acquired to date?Humanwell Healthcare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Humanwell Healthcare has invested to date?Humanwell Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Humanwell Healthcare

Lists including Humanwell Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial